WallStreetZenWallStreetZen

NASDAQ: ENGN
Engene Therapeutics Inc Stock Ownership - Who owns Engene Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Engene Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William GrossmanMed;Interim2026-09-225,102$1.97
$10.05kBuy

1 of 1

ENGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ENGN insiders and whales buy or sell their stock.

ENGN Shareholders

What type of owners hold Engene Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Forbion Growth Opportunities Fund I Cooperatief Ua10.14%6,798,362$10.74MInsider
Lumira Capital Investment Management Inc5.74%3,849,299$6.08MInsider
De Solidarite Des Travailleurs Du Quebec Fonds4.53%3,036,153$4.80MInsider
Forbion Capital Fund III Cooperatief Ua4.32%2,894,735$4.57MInsider
Growth Sponsor Feac I. Bv Forbion2.98%2,000,000$3.16MInsider
Gerald A. Brunk0.23%152,974$241.70kInsider
Bvf Partners L P0.16%104,257$164.73kInsider
Anthony Tzeyew Cheung0.15%102,873$162.54kInsider
Richard M. Glickman0.04%24,675$38.99kInsider
Philip Astleysparke0.03%20,000$31.60kInsider

1 of 3

ENGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENGN0.07%28.37%Net BuyingNet Buying
VANI0.00%100.00%Net Buying
CBUS0.02%64.61%Net Buying
VTVT0.00%100.00%
PMN0.02%99.98%Net BuyingNet Buying
View Top Biotech Stocks

Engene Therapeutics Stock Ownership FAQ

Who owns Engene Therapeutics?

Engene Therapeutics (NASDAQ: ENGN) is owned by 0.07% institutional shareholders, 28.37% Engene Therapeutics insiders, and 71.55% retail investors. Forbion Growth Opportunities Fund I Cooperatief Ua is the largest individual Engene Therapeutics shareholder, owning 6.80M shares representing 10.14% of the company. Forbion Growth Opportunities Fund I Cooperatief Ua's Engene Therapeutics shares are currently valued at $10.40M.

If you're new to stock investing, here's how to buy Engene Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.